Phase 3 trials of retatrutide named the Triumph trials will provide invaluable insights into the long term weight-loss results of retatrutide as well as its potential impact on obesity-related conditions, such as osteoarthritis and obstructive sleep apnea
Central GLP-1 receptors: novel molecular targets for cocaine use disorder
Tirzepatide and phentermine Combining GLP-1 agonists with phentermine is a topic that generates significant interest
Zepbound Insurance Coverage by Plan Type Insurance coverage for Zepbound depends on several factors, including your specific plan type, whether you meet certain prescribing criteria, and the formulary decisions made by pharmacy benefit managers
All medications you are currently takingincluding insulin, sulfonylureas, over-the-counter drugs, and supplementsas some combinations may increase the risk of hypoglycemia
The FDA position is that these salt forms are not the same as the semaglutide base used in approved products like Ozempic and Wegovy